Response: Commentary: An In Silico–In Vitro Pipeline Identifying an 
HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune 
Response in Cancer Patients

Mishto, M.; Rodriguez-Hernandez, G.; Neefjes, J.; Urlaub, H.; Liepe, J.

doi:10.3389/fimmu.2021.679836

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

このアイテムの新しいバージョンが利用可能です:
https://pure.mpg.de/pubman/item/item_3398348_2

詳細要約

公開

学術論文

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

MPS-Authors

/persons/resource/persons15947

Urlaub, H.
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons208298

Liepe, J.
Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

3398348.pdf
(出版社版), 5MB

付随資料 (公開)

There is no public supplementary material available

引用

Mishto, M., Rodriguez-Hernandez, G., Neefjes, J., Urlaub, H., & Liepe, J. (2021). Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients. Frontiers in Immunology, 12:. doi:10.3389/fimmu.2021.679836.

引用: https://hdl.handle.net/21.11116/0000-000A-D2A4-F

要旨

要旨はありません